2,019 results on '"Martin, Paul J."'
Search Results
2. Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA)
3. Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathway
4. Steroid tapering after GVHD Rx: not too fast, not too slow
5. Trafficking between clonally related peripheral T-helper cells and tissue-resident T-helper cells in chronic GVHD
6. Prediction of outcomes after second-line treatment for acute graft-versus-host disease
7. Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation
8. Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin
9. Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD
10. Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival
11. Genetic variants associated with inflammatory bowel disease and gut graft-versus-host disease
12. CD24Fc to DAMPen GVHD
13. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report
14. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report
15. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report
16. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report
17. Noise reduction of a Libbrecht--Hall style current driver
18. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report
19. Impact of Donor Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
20. Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation
21. A combined biomarker and clinical panel for chronic graft versus host disease diagnosis
22. A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease
23. Disability Related to Chronic Graft-versus-Host Disease
24. Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia
25. Chronic graft-versus-host-disease treatment in Brazil: analyses of failure-free survival
26. Obligation for transparency regarding treating physician credentials at academic health centres
27. IL-22-dependent dysbiosis and mononuclear phagocyte depletion contribute to steroid-resistant gut graft-versus-host disease in mice
28. The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index
29. HLA Typing in Support of Hematopoietic Cell Transplantation from Unrelated Donors
30. A guide to research partnerships for pragmatic clinical trials
31. Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients
32. Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease
33. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial
34. Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning
35. High passive-stability diode-laser design for use in atomic-physics experiments
36. Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD
37. Donor T cell STAT3 deficiency enables tissue PD-L1–dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activity
38. Two-Way Nesting in a Split-Implicit Ocean Model: NCOM
39. Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis
40. Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors
41. Educating Radiologists for Self-governance
42. Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease
43. Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes
44. Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity
45. Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease
46. Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease
47. Association of Plasma CD163 Concentration with De Novo–Onset Chronic Graft-versus-Host Disease
48. An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease
49. Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation
50. CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.